Approach to Bone Health in the Patient With Breast Cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38864566.
- Also identified by DOI 10.1210/clinem/dgae404.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment for breast cancer, including endocrine therapies, can contribute to bone loss and increase the risk of osteoporosis and fractures. Management of bone health in patients with cancer is often coordinated between oncologists, endocrinologists, and primary care physicians. In this article, we discuss the approach to screening for fracture risk among patients initiating treatments for breast cancer and recommendations for lifestyle modifications to optimize bone health. We will review 3 indications for pharmacologic bone-targeted therapies: prevention of cancer treatment-induced bone loss, adjuvant therapy to reduce recurrence, and management of bone metastases.
Medical subject headings
- Breast Neoplasms
- Osteoporosis
- Bone Neoplasms